<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04008056</url>
  </required_header>
  <id_info>
    <org_study_id>NIMAO/2017-03/MF-01</org_study_id>
    <nct_id>NCT04008056</nct_id>
  </id_info>
  <brief_title>Impact of Patient Reported Outcomes for Pre-chemotherapy Medical Decision in Day Patients With Digestive Cancer</brief_title>
  <acronym>PRO Link</acronym>
  <official_title>Impact of Patient Reported Outcomes for Pre-chemotherapy Medical Decision in Day Patients With Digestive Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that an early assessment of the clinical toxicity of the
      patient is possible via patient reported outcomes and that this information provides at least
      the same information level as the clinical examination of the patient made by the doctor. The
      early decision to prepare chemotherapy medications based on the indirect early collection of
      clinical information from the patient via a patient reported outcome should help minimize the
      number of chemotherapy medications destroyed.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 9, 2019</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Authorization for preparation of chemotherapy based on clinical information (decision 2)</measure>
    <time_frame>Day 1</time_frame>
    <description>Yes/no</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Authorization for preparation of chemotherapy based on patient reported outcome (decision 3)</measure>
    <time_frame>Day 1</time_frame>
    <description>Yes/no</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cost of unused pouches of prepared chemotherapy according to decisions</measure>
    <time_frame>Day 1</time_frame>
    <description>Euros</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Authorization for preparation of chemotherapy based on biological results (decision 1)</measure>
    <time_frame>Day 0</time_frame>
    <description>Yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction with the patient reported outcome questionnaire</measure>
    <time_frame>Before starting chemotherapy (Up to 72 hours prior to treatment starting)</time_frame>
    <description>System Usability Scale (SUS); score between 0-100 where the higher the score, the more satisfied the patient is.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">138</enrollment>
  <condition>Digestive Cancer</condition>
  <arm_group>
    <arm_group_label>Patients undergoing chemotherapy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patient Reported Outcome questionnaire</intervention_name>
    <description>34 question form to assess patient symptoms</description>
    <arm_group_label>Patients undergoing chemotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Day patients treated by chemotherapy for a digestive tumor in the Oncology Department of
        Nimes hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient must have given their free and informed consent and signed the consent
             form

          -  The patient must be a member or beneficiary of a health insurance plan

          -  Patient is undergoing at least their second chemotherapy regime (outside weekly scheme
             or protocol with cisplatin requiring hospitalization) for a digestive tumor

          -  Patient has a Smartphone or access to the internet (via tablet or computer)

          -  The patient is under consultation as a day patient in the Oncology Department of Nimes
             hosptial

        Exclusion Criteria:

          -  The subject is participating in a category 1 interventional study, or is in a period
             of exclusion determined by a previous study

          -  The subject refuses to sign the consent

          -  It is impossible to give the subject informed information

          -  The patient is under safeguard of justice or state guardianship

          -  The patient is pregnant, parturient or breastfeeding

          -  Patient has already participated in the study

          -  Patient undergoing first chemotherapy regime
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mireille Favier</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Nimes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mireille Favier</last_name>
    <phone>04.66.68.32.92</phone>
    <email>mireille.favier@chu-nimes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Nimes</name>
      <address>
        <city>Nimes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anissa Megzari</last_name>
      <phone>04.66.68.42.36</phone>
      <email>drc@chu-nimes.fr</email>
    </contact>
    <investigator>
      <last_name>Mireille Favier</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphane Obled</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valérie Phoutthasang</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Virginie Loriot</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrice Wolff</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christelle Cousin</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Géraldine Leguelinel-Blache</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bénédicte Brunaud-Gagniard</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>July 2, 2019</study_first_submitted>
  <study_first_submitted_qc>July 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2019</study_first_posted>
  <last_update_submitted>September 16, 2019</last_update_submitted>
  <last_update_submitted_qc>September 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastrointestinal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

